Skip to main content
Top
Published in: Advances in Gerontology 3/2020

01-07-2020 | Testosterone

Hormonal Characteristics of Androgen Status in Males of Different Age Groups

Authors: V. G. Selyatitskaya, E. A. Epanchintseva, E. G. Novikova, N. I. Shilina, B. B. Pinkhasov

Published in: Advances in Gerontology | Issue 3/2020

Login to get access

Abstract

Males (n = 374) aged 20–69 years were divided into five age groups and examined: first group was aged 20–29 years; the second, 30–39 years; the third, 40–49 years; the fourth, 50–59 years; and the fifth, 60–69 years. The average content of total testosterone in the blood serum in all males was 16.1 ± 7 nmol/L. Hormonal traits of androgen deficiency, the frequency of which increased with age, were detected in males of the second group as compared with those of the first group. The frequency of androgen deficiency (total testosterone level <12.1 nmol/L) in the first group was 26.9%; it did not differ in the second, third, and fourth groups (30.6–33.9%). The frequency of androgen deficiency in the fifth group was 44%. The frequency of hormonal traits of hypogonadism (total testosterone level <8 nmol/L) did not differ significantly in groups 1–4 (6.2–9.3%) and increased only in the fifth group (28%). The age-related androgen deficiency was associated in males with a decrease in the androgen function of not only gonads but also adrenal glands, an increase in the level of sex steroid-binding globulin in the blood, and an increase in the metabolism of testosterone to estradiol, and it was accompanied by a compensatory increase in the synthesis of luteinizing hormone in the pituitary gland.
Literature
1.
go back to reference Borisov, V.V. and Shilov, E.M., Androgen deficiency in the elderly and senile: a multidisciplinary study, Klin. Gerontol., 2007, no. 11, pp. 20–23. Borisov, V.V. and Shilov, E.M., Androgen deficiency in the elderly and senile: a multidisciplinary study, Klin. Gerontol., 2007, no. 11, pp. 20–23.
2.
go back to reference Dedov, I.I., Mel’nichenko, G.A., Rozhivanov, R.V., and Kurbatov, D.G., Recommendations for the diagnostics and treatment of testosterone deficiency (hypogonadism) in men. https://www.endocrincentr.ru/sites/default/files/specialists/science/clinicreco-mendations/hypogon.pdf. Accessed May 23, 2019. Dedov, I.I., Mel’nichenko, G.A., Rozhivanov, R.V., and Kurbatov, D.G., Recommendations for the diagnostics and treatment of testosterone deficiency (hypogonadism) in men. https://​www.​endocrincentr.​ru/​sites/​default/​files/​specialists/​science/​clinicreco-mendations/​hypogon.​pdf.​ Accessed May 23, 2019.
3.
go back to reference Zvezdina, N.V. and Ivanova, L.V., Life expectancy in Russia and impact factors, Vopr. Stat., 2015, no. 7, pp. 10–20. Zvezdina, N.V. and Ivanova, L.V., Life expectancy in Russia and impact factors, Vopr. Stat., 2015, no. 7, pp. 10–20.
4.
go back to reference Novikova, E.G., Selytitskaya, V.G., Lutov, Yu.V., and Mitrofanov, I.M., The relationship of hypogonadism with metabolic syndrome in men of different age groups, Vestn. Novosib. Gos. Univ., Ser. Biol.,Klin. Med., 2012, vol. 10, no. 1, pp. 54–62. Novikova, E.G., Selytitskaya, V.G., Lutov, Yu.V., and Mitrofanov, I.M., The relationship of hypogonadism with metabolic syndrome in men of different age groups, Vestn. Novosib. Gos. Univ., Ser. Biol.,Klin. Med., 2012, vol. 10, no. 1, pp. 54–62.
5.
go back to reference Tyuzikov, I.A., The results of a pilot epidemiological study of the rate of androgen deficiency in men in the ambulatory practice of physiciants of various specialties (Yaroslavl study), Androl. Genital’naya Khir., 2013, no. 3, pp. 23–28. Tyuzikov, I.A., The results of a pilot epidemiological study of the rate of androgen deficiency in men in the ambulatory practice of physiciants of various specialties (Yaroslavl study), Androl. Genital’naya Khir., 2013, no. 3, pp. 23–28.
7.
go back to reference Brahimaj, A., Muka, T., Kavousi, M., et al., Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study, Diabetologia, 2017, vol. 60, pp. 98–106.PubMedCrossRef Brahimaj, A., Muka, T., Kavousi, M., et al., Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study, Diabetologia, 2017, vol. 60, pp. 98–106.PubMedCrossRef
8.
go back to reference Dimopoulou, C., Goulis, D.G., Corona, G., and Maggi, M., The complex association between metabolic syndrome and male hypogonadism, Metabolism, 2018, vol. 86, pp. 61–68.PubMedCrossRef Dimopoulou, C., Goulis, D.G., Corona, G., and Maggi, M., The complex association between metabolic syndrome and male hypogonadism, Metabolism, 2018, vol. 86, pp. 61–68.PubMedCrossRef
9.
go back to reference Dohle, G.R., Arver, S., Bettocchi, C., et al., EAU guidelines on male hypogonadism. https://uroweb.org/ wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2016.pdf. Accessed April 10, 2019. Dohle, G.R., Arver, S., Bettocchi, C., et al., EAU guidelines on male hypogonadism. https://​uroweb.​org/​ wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2016.pdf. Accessed April 10, 2019.
10.
go back to reference Feldman, H.A., Longcope, C., Derby, C.A., et al., Age trends in the level of serum testosterone and other hormones in middleaged men: longitudinal results from the Massachusetts male aging study, J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 2, pp. 589–598.PubMedCrossRef Feldman, H.A., Longcope, C., Derby, C.A., et al., Age trends in the level of serum testosterone and other hormones in middleaged men: longitudinal results from the Massachusetts male aging study, J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 2, pp. 589–598.PubMedCrossRef
11.
go back to reference Gabrielsen, J.S. and Tanrikut, C., Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis, Andrology, 2016, vol. 4, pp. 648–661.PubMedCrossRef Gabrielsen, J.S. and Tanrikut, C., Chronic exposures and male fertility: the impacts of environment, diet, and drug use on spermatogenesis, Andrology, 2016, vol. 4, pp. 648–661.PubMedCrossRef
12.
go back to reference Hall, S.A., Esche, G.R., Araujo, A.B., et al., Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample, J. Clin. Endocrinol. Metab., 2008, vol. 93, no. 10, pp. 3870–3877.PubMedPubMedCentralCrossRef Hall, S.A., Esche, G.R., Araujo, A.B., et al., Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample, J. Clin. Endocrinol. Metab., 2008, vol. 93, no. 10, pp. 3870–3877.PubMedPubMedCentralCrossRef
13.
go back to reference Harman, S.M., Metter, E.J., Tobin, J.D., et al., Longitudinal effects of aging on serum total and free testosterone levels in healthy men, J. Clin. Endocrinol. Metab., 2000, vol. 86, no. 2, pp. 724–731.CrossRef Harman, S.M., Metter, E.J., Tobin, J.D., et al., Longitudinal effects of aging on serum total and free testosterone levels in healthy men, J. Clin. Endocrinol. Metab., 2000, vol. 86, no. 2, pp. 724–731.CrossRef
14.
go back to reference Kuzina, I.N., Kilikovsky, V.V., and Smirnova, O.V., Age-related changes in the blood concentrations of the hypothalamic-pituitaryandrenal axis hormones in healthy men: relations with other hormonal axes, Hum. Physiol., 2010, vol. 36, no. 5, pp. 582–589.CrossRef Kuzina, I.N., Kilikovsky, V.V., and Smirnova, O.V., Age-related changes in the blood concentrations of the hypothalamic-pituitaryandrenal axis hormones in healthy men: relations with other hormonal axes, Hum. Physiol., 2010, vol. 36, no. 5, pp. 582–589.CrossRef
15.
go back to reference Livingston, M., Kalansooriya, A., Hartland, A.J., et al., Serum testosterone levels in male hypogonadism: Why and when to check—a review, Int. J. Clin. Pract., 2017, vol. 71, p. e12995.PubMedCentralCrossRef Livingston, M., Kalansooriya, A., Hartland, A.J., et al., Serum testosterone levels in male hypogonadism: Why and when to check—a review, Int. J. Clin. Pract., 2017, vol. 71, p. e12995.PubMedCentralCrossRef
16.
go back to reference Lunenfeld, B., Saad, F., and Hoels, C.E., ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and ratuionale, Aging Male, 2005, vol. 8, no. 2, pp. 59–74.PubMedCrossRef Lunenfeld, B., Saad, F., and Hoels, C.E., ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and ratuionale, Aging Male, 2005, vol. 8, no. 2, pp. 59–74.PubMedCrossRef
17.
go back to reference Starka, L., Duskova, M., and Hill, M., Dehydroepiandrosterpne: a neuroactive steroid, J. Steroid Biochem. Mol. Biol., 2015, vol. 145, pp. 254–260.PubMedCrossRef Starka, L., Duskova, M., and Hill, M., Dehydroepiandrosterpne: a neuroactive steroid, J. Steroid Biochem. Mol. Biol., 2015, vol. 145, pp. 254–260.PubMedCrossRef
18.
go back to reference Travison, T.G., Araujo, A.B., O’Donnell, A.B., et al., A population-level decline in serum testosterone levels in American men, J. Clin. Endocrinol. Metab., 2007, vol. 92, no. 1, pp. 196–202.PubMedCrossRef Travison, T.G., Araujo, A.B., O’Donnell, A.B., et al., A population-level decline in serum testosterone levels in American men, J. Clin. Endocrinol. Metab., 2007, vol. 92, no. 1, pp. 196–202.PubMedCrossRef
19.
go back to reference Vermeulen, A., Kaufman, J.M., and Glagulli, V.A., Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males, J. Clin. Endocrinol. Metab., 1996, vol. 81, no. 5, pp. 1821–1826.PubMed Vermeulen, A., Kaufman, J.M., and Glagulli, V.A., Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males, J. Clin. Endocrinol. Metab., 1996, vol. 81, no. 5, pp. 1821–1826.PubMed
20.
go back to reference Vermeulen, A., Kaufman, J.M., Goemaere, S., and van Pottelberg, I., Estradiol in elderly men, Aging Male, 2002, vol. 5, no. 2, pp. 98–102.PubMedCrossRef Vermeulen, A., Kaufman, J.M., Goemaere, S., and van Pottelberg, I., Estradiol in elderly men, Aging Male, 2002, vol. 5, no. 2, pp. 98–102.PubMedCrossRef
Metadata
Title
Hormonal Characteristics of Androgen Status in Males of Different Age Groups
Authors
V. G. Selyatitskaya
E. A. Epanchintseva
E. G. Novikova
N. I. Shilina
B. B. Pinkhasov
Publication date
01-07-2020
Publisher
Pleiades Publishing
Published in
Advances in Gerontology / Issue 3/2020
Print ISSN: 2079-0570
Electronic ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057020030169

Other articles of this Issue 3/2020

Advances in Gerontology 3/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.